Finance

Lists
1MDGL:BIT
Madrigal Pharmaceuticals Inc
€460.00
-0.56%
(-2.60) 1D
Aug 27, 3:09:51 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1MDGL...
Mkt. cap
12.33B
Avg. vol.
2.00
Volume
0.00
52-wk high
€518.20
52-wk low
€352.90
No. of employees
915
Mkt. cap
12.33B
Avg. vol.
2.00
Volume
0.00
52-wk high
€518.20
52-wk low
€352.90
No. of employees
915
News stories
From web sources and news partners
About Madrigal Pharmaceuticals Inc
CEOPaul A. Friedman
Employees915
Founded2011
HeadquartersWest Conshohocken, Pennsylvania, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
287.27M
321.08M
311.34M
364.25M
Cost of goods sold
18.12M
24.45M
26.85M
40.01M
Cost of revenue
18.12M
24.45M
26.85M
40.01M
Research and development expenses
174.00M
116.27M
108.69M
91.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
209.12M
239.98M
268.52M
289.38M
Operating expense
383.12M
356.24M
377.21M
380.55M
Total operating expenses
401.24M
380.69M
404.06M
420.56M
Operating income
-113.98M
-59.61M
-92.72M
-56.31M
Other non operating income
-293.00K
-128.00K
-
-
EBT including unusual items
-114.19M
-58.58M
-94.39M
-57.94M
EBT excluding unusual items
-111.41M
-58.58M
-94.39M
-57.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-114.19M
-58.58M
-94.39M
-57.94M
Net profit margin
-39.75%
-18.24%
-30.32%
-15.91%
Earnings per share
-4.96
-2.57
-1.38
-1.99
Interest and investment income
10.31M
9.46M
8.24M
7.10M
Interest expense
-7.45M
-8.30M
-7.82M
-7.94M
Net interest expenses
2.86M
1.16M
424.00K
-836.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-113.62M
-59.22M
-92.34M
-55.93M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps